MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 146 filers reported holding MACROGENICS INC in Q4 2020. The put-call ratio across all filers is 4.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,573,546 | -12.2% | 4,414,924 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $23,425,124 | -26.9% | 4,378,528 | -2.0% | 0.00% | 0.0% |
| Q1 2023 | $32,038,421 | +7.4% | 4,468,399 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $29,821,683 | +106.1% | 4,444,364 | +6.3% | 0.00% | – |
| Q3 2022 | $14,470,000 | +24.8% | 4,182,241 | +6.4% | 0.00% | – |
| Q2 2022 | $11,596,000 | -67.4% | 3,930,962 | -2.5% | 0.00% | -100.0% |
| Q1 2022 | $35,524,000 | -43.9% | 4,032,239 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $63,335,000 | -22.4% | 3,946,178 | +1.3% | 0.00% | -50.0% |
| Q3 2021 | $81,585,000 | -22.9% | 3,896,140 | -1.1% | 0.00% | -33.3% |
| Q2 2021 | $105,857,000 | -13.3% | 3,941,064 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $122,121,000 | +49.4% | 3,834,274 | +7.2% | 0.00% | +50.0% |
| Q4 2020 | $81,738,000 | -1.7% | 3,575,584 | +8.3% | 0.00% | -33.3% |
| Q3 2020 | $83,147,000 | -9.3% | 3,300,787 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $91,630,000 | +384.5% | 3,281,884 | +1.0% | 0.00% | +200.0% |
| Q1 2020 | $18,912,000 | -45.8% | 3,249,328 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $34,919,000 | -14.8% | 3,209,530 | -0.1% | 0.00% | -50.0% |
| Q3 2019 | $40,995,000 | -24.5% | 3,212,847 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $54,275,000 | -0.6% | 3,198,214 | +5.3% | 0.00% | 0.0% |
| Q1 2019 | $54,593,000 | +68.5% | 3,036,294 | +19.0% | 0.00% | +100.0% |
| Q4 2018 | $32,399,000 | -33.4% | 2,551,127 | +12.4% | 0.00% | -50.0% |
| Q3 2018 | $48,680,000 | +12.0% | 2,270,541 | +7.9% | 0.00% | 0.0% |
| Q2 2018 | $43,459,000 | +2.3% | 2,104,604 | +24.6% | 0.00% | 0.0% |
| Q1 2018 | $42,501,000 | +43.0% | 1,689,223 | +8.0% | 0.00% | +100.0% |
| Q4 2017 | $29,728,000 | +5.8% | 1,564,656 | +2.9% | 0.00% | 0.0% |
| Q3 2017 | $28,098,000 | +15.3% | 1,520,407 | +9.3% | 0.00% | 0.0% |
| Q2 2017 | $24,362,000 | -3.2% | 1,391,322 | +2.8% | 0.00% | 0.0% |
| Q1 2017 | $25,163,000 | -5.9% | 1,352,864 | +3.4% | 0.00% | 0.0% |
| Q4 2016 | $26,740,000 | -31.1% | 1,308,184 | +0.8% | 0.00% | -50.0% |
| Q3 2016 | $38,828,000 | +11.3% | 1,298,159 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $34,876,000 | +62.8% | 1,292,202 | +13.1% | 0.00% | +100.0% |
| Q1 2016 | $21,424,000 | -37.2% | 1,142,591 | +3.8% | 0.00% | -50.0% |
| Q4 2015 | $34,099,000 | +47.9% | 1,101,054 | +2.3% | 0.00% | +100.0% |
| Q3 2015 | $23,049,000 | -24.4% | 1,076,037 | +34.1% | 0.00% | -50.0% |
| Q2 2015 | $30,472,000 | +35.0% | 802,539 | +11.5% | 0.00% | 0.0% |
| Q1 2015 | $22,568,000 | +12.8% | 719,448 | +26.1% | 0.00% | +100.0% |
| Q4 2014 | $20,008,000 | +68.9% | 570,530 | +0.7% | 0.00% | 0.0% |
| Q3 2014 | $11,843,000 | +40.2% | 566,627 | +45.8% | 0.00% | 0.0% |
| Q2 2014 | $8,445,000 | +25.4% | 388,644 | +60.5% | 0.00% | 0.0% |
| Q1 2014 | $6,737,000 | +98.9% | 242,084 | +96.0% | 0.00% | – |
| Q4 2013 | $3,387,000 | – | 123,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |